Skip to content
AMCHAM-Logo-1
  • About
    • About us
    • National Executive Board
    • Secretariat
  • Events
    • Upcoming Events
    • Past Events
  • Communication
    • Publications
    • Annual Report
  • Committees
  • Membership
    • Membership Benefits
    • Pay Now
  • Advocacy
  • Contact us
Become a Member

Pharma Committee

AmCham submitted comments on the Proposed Revised Guidelines for Similar Biologics to Drugs Controller General India (DCGI)

Pharma Committee / January 22, 2024

These recommendations were submitted by AmCham Pharma Committee to Drugs Controller General India (DCGI) on 26th April 2016.

AmCham submitted comments on the Proposed Revised Guidelines for Similar Biologics to Drugs Controller General India (DCGI) Read More »

Pharma Committee

AmCham submitted comments on the Proposed Revised Guidelines for Similar Biologics to Drugs Controller General India (DCGI)

Pharma Committee / May 19, 2016

These recommendations were submitted by AmCham Pharma Committee to Drugs Controller General India (DCGI) on 26th April 2016.

AmCham submitted comments on the Proposed Revised Guidelines for Similar Biologics to Drugs Controller General India (DCGI) Read More »

Pharma Committee

123 Fifth Avenue, NY 10160, New York, USA | Phone: 800-123-456 | Email: contact@example.com

Copyright © 2025 AMCHAM India

  • Home
  • About
  • National Executive Board
  • Secretariat
  • Membership
  • Committees
  • Events
  • Advocacy
  • Publications
  • Annual Report
  • Terms & Conditions
  • Privacy Policy
  • Pricing & Refund Policy
  • Contact
Affiliations

Lets Stay Connected


Follow Us On :
American Chamber of Commerce in India

PHD House, 4th floor, 4/2, Siri Instituational
Area August Kranti Marg New Delhi-110 016

  • Tel : 91-11-2654 1200,
  • 91-11-4650 9413
  • Email : amcham@amchamindia.com